Evidence map›Paper›PMID 40827781›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Superhydrophobic Cell-Repellent Microstructures: Plastron-Mediated Inhibition of A549 Epithelial Cell Adhesion.

Mohammad Awashra, Ville Jokinen

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammad AwashraSchool of Chemical Engineering, Department of Chemistry and Materials Science, Aalto University, Tietotie 3, Espoo, 02150, Finland.ORCID 0000-0003-0136-9830
Ville JokinenSchool of Chemical Engineering, Department of Chemistry and Materials Science, Aalto University, Tietotie 3, Espoo, 02150, Finland.ORCID 0000-0001-6347-7461

Funding

Luonnontieteiden ja Tekniikan Tutkimuksen Toimikunta 341459
6 · The paper itself

Abstract

Control of cell adhesion is essential for biomedical devices, biosensors, and anti-fouling coatings. Here, adhesion of A549 epithelial cells is systematically evaluated on silicon substrates with tunable wettability (superhydrophilic to superhydrophobic) and topography (smooth, nanostructured, and micropillared). Superhydrophobic surfaces stabilize a trapped air plastron that minimizes solid-liquid contact, enabling plastron-mediated physical repellency of cells. The most cell-repellent surface, composed of 5 µm micropillars with a 7.4% solid-liquid contact fraction, reduced cell density by ≈83% versus a smooth hydrophobic control and ≈95% versus a hydrophilic control at 4 h, and by ≈90% and ≈93%, respectively, after 24 h of incubation, corresponding to an approximate tenfold decrease in cell adhesion. Micropillar arrays outperform nanostructures in resisting cell attachment, owing to large air-filled gaps exceeding 10 µm that physically prevent cell adhesion. A trade-off is observed: lower solid-fraction micropillars provide greater short-term repellency but lose the plastron over time, enabling delayed fouling, whereas higher-fraction structures preserve the air layer beyond 72 h but are initially less cell-repellent due to higher effective cell contact area and smaller air gaps. These results establish that optimized microscale superhydrophobic textures achieve superior and time-dependent bio-repellency and introduce a rational design strategy for non-fouling materials.

Indexed as

Cell AdhesionEpithelial CellsA549 CellsHumansHydrophobic and Hydrophilic InteractionsNanostructuresSurface PropertiesWettabilityair plastronbiointerfacecell adhesionmicrostructuresphysical repellencysuperhydrophobic

Identifiers

PMID40827781
PMCPMC12508712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.